News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Autoimmune Biotech Xencor Files for a $69 Million IPO



10/11/2013 7:34:08 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Xencor, a clinical-stage biotech developing treatments for severe autoimmune and allergic diseases and cancer, filed on Friday with the SEC to raise up to $69 million in an initial public offering.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at News Release


comments powered by Disqus
Xencor
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES